journal
https://read.qxmd.com/read/36949462/comprehensive-analyses-of-a-12-metabolism-associated-gene-signature-and-its-connection-with-tumor-metastases-in-clear-cell-renal-cell-carcinoma
#1
JOURNAL ARTICLE
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Xiaoping Zhang
BACKGROUND: The outcomes of patients with clear cell renal cell carcinoma (ccRCC) were dreadful due to lethal local recurrence and distant metastases. Accumulating evidence suggested that ccRCC was considered a metabolic disease and metabolism-associated genes (MAGs) exerted essential functions in tumor metastases. Thus, this study intends to seek whether the dysregulated metabolism promotes ccRCC metastases and explores underlying mechanisms. METHOD: Weighted gene co-expression network analysis (WGCNA) was employed based on 2131 MAGs to select genes mostly associated with ccRCC metastases for subsequent univariate Cox regression...
March 23, 2023: BMC Cancer
https://read.qxmd.com/read/36949413/impact-of-covid-19-in-patients-on-active-melanoma-therapy-and-with-history-of-melanoma
#2
JOURNAL ARTICLE
Douglas B Johnson, Michael B Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Joy Awosika, Ziad Bakouny, Chris Labaki, Renee Maria Saliby, Clara Hwang, Sunny R K Singh, Nino Balanchivadze, Christopher R Friese, Leslie A Fecher, James J Yoon, Brandon Hayes-Lattin, Mehmet A Bilen, Cecilia A Castellano, Gary H Lyman, Lisa Tachiki, Sumit A Shah, Michael J Glover, Daniel B Flora, Elizabeth Wulff-Burchfield, Anup Kasi, Saqib H Abbasi, Dimitrios Farmakiotis, Kendra Viera, Elizabeth J Klein, Lisa B Weissman, Chinmay Jani, Matthew Puc, Catherine C Fahey, Daniel Y Reuben, Sanjay Mishra, Alicia Beeghly-Fadiel, Benjamin French, Jeremy L Warner
INTRODUCTION: COVID-19 particularly impacted patients with co-morbid conditions, including cancer. Patients with melanoma have not been specifically studied in large numbers. Here, we sought to identify factors that associated with COVID-19 severity among patients with melanoma, particularly assessing outcomes of patients on active targeted or immune therapy. METHODS: Using the COVID-19 and Cancer Consortium (CCC19) registry, we identified 307 patients with melanoma diagnosed with COVID-19...
March 23, 2023: BMC Cancer
https://read.qxmd.com/read/36949454/identification-of-zbtb4-as-an-immunological-biomarker-that-can-inhibit-the-proliferation-and-invasion-of-pancreatic-cancer
#3
JOURNAL ARTICLE
Zhe Yang, Feiran Chen, Feng Wang, Xiubing Chen, Biaolin Zheng, Xiaomin Liao, Zhejun Deng, Xianxian Ruan, Jing Ning, Qing Li, Haixing Jiang, Shanyu Qin
BACKGROUND: Zinc finger and BTB domain-containing protein 4 (ZBTB4) belongs to the zinc finger protein family, which has a role in regulating epigenetic inheritance and is associated with cell differentiation and proliferation. Previous studies have identified aberrant ZBTB4 expression in cancer and its ability to modulate disease progression, but studies on the immune microenvironment, immunotherapy and its role in cancer are still lacking. METHODS: Human pan-cancer and normal tissue transcriptome data were obtained from The Cancer Genome Atlas...
March 22, 2023: BMC Cancer
https://read.qxmd.com/read/36944978/radiomics-nomogram-for-preoperative-differentiation-of-pulmonary-mucinous-adenocarcinoma-from-tuberculoma-in-solitary-pulmonary-solid-nodules
#4
JOURNAL ARTICLE
Junjie Zhang, Ligang Hao, MingWei Qi, Qian Xu, Ning Zhang, Hui Feng, Gaofeng Shi
OBJECTIVE: To develop and validate predictive models using clinical parameters, radiomic features and a combination of both for preoperative differentiation of pulmonary nodular mucinous adenocarcinoma (PNMA) from pulmonary tuberculoma (PTB). METHOD: A total of 124 and 53 patients with PNMA and PTB, respectively, were retrospectively analyzed from January 2017 to November 2022 in The Fourth Affiliated Hospital of Hebei Medical University (Ligang et al., A machine learning model based on CT and clinical features to distinguish pulmonary nodular mucinous adenocarcinoma from tuberculoma, 2023)...
March 21, 2023: BMC Cancer
https://read.qxmd.com/read/36944930/feasibility-and-preliminary-efficacy-of-a-virtual-reality-intervention-targeting-distress-and-anxiety-in-primary-brain-tumor-patients-at-the-time-of-clinical-evaluation-study-protocol-for-a-phase-2-clinical-trial
#5
JOURNAL ARTICLE
Amanda L King, Alvina A Acquaye-Mallory, Elizabeth Vera, Tito Mendoza, Jennifer Reyes, Macy L Stockdill, Mark R Gilbert, Terri S Armstrong
BACKGROUND: Primary brain tumor (PBT) patients experience higher levels of distress and anxiety than other solid tumor patients, particularly at the time of clinical evaluation when uncertainty about disease status is high ("scanxiety"). There is promising evidence supporting use of virtual reality (VR) to target psychological symptoms in other solid tumor patients, though PBT patients have not been studied extensively in this context. The primary aim of this phase 2 clinical trial is to establish the feasibility of a remote VR-based relaxation intervention for a PBT population, with secondary aims designed to determine preliminary efficacy of improving distress and anxiety symptoms...
March 21, 2023: BMC Cancer
https://read.qxmd.com/read/36941595/tuba1c-a-new-potential-target-of-lncrna-egfr-as1-promotes-gastric-cancer-progression
#6
JOURNAL ARTICLE
Haodong Wang, Huaiping Cui, Xinjun Yang, Lipan Peng
BACKGROUND: The lack of obvious symptoms of early gastric cancer (GC) as well as the absence of sensitive and specific biomarkers results in poor clinical outcomes. Tubulin is currently emerging as important regulators of the microtubule cytoskeleton and thus have a strong potential to be implicated in a number of disorders, however, its mechanism of action in gastric cancer is still unclear. Tubulin alpha-1 C (TUBA1C) is a subtype of α-tubulin, high TUBA1C expression has been shown to be closely related to a poor prognosis in various cancers, this study, for the first time, revealed the mechanism of TUBA1C promotes malignant progression of gastric cancer in vitro and in vivo...
March 20, 2023: BMC Cancer
https://read.qxmd.com/read/36941575/ctdna-guided-adjuvant-chemotherapy-versus-standard-of-care-adjuvant-chemotherapy-after-curative-surgery-in-patients-with-high-risk-stage-ii-or-stage-iii-colorectal-cancer-a-multi-centre-prospective-randomised-control-trial-tracc-part-c
#7
RANDOMIZED CONTROLLED TRIAL
Susanna Slater, Annette Bryant, Hsiang-Chi Chen, Ruwaida Begum, Isma Rana, Maria Aresu, Clare Peckitt, Oleg Zhitkov, Retchel Lazaro-Alcausi, Victoria Borja, Rachel Powell, David Lowery, Michael Hubank, Thereasa Rich, Gayathri Anandappa, Ian Chau, Naureen Starling, David Cunningham
BACKGROUND: Circulating tumour DNA (ctDNA) to detect minimal residual disease (MRD) is emerging as a biomarker to predict recurrence in patients with curatively treated early stage colorectal cancer (CRC). ctDNA risk stratifies patients to guide adjuvant treatment decisions. We are conducting the UK's first multi-centre, prospective, randomised study to determine whether a de-escalation strategy using ctDNA to guide adjuvant chemotherapy (ACT) decisions is non-inferior to standard of care (SOC) chemotherapy, as measured by 3-year disease free survival (DFS) in patients with resected CRC with no evidence of MRD (ctDNA negative post-operatively)...
March 20, 2023: BMC Cancer
https://read.qxmd.com/read/36941558/association-of-smoking-alcohol-and-coffee-consumption-with-the-risk-of-ovarian-cancer-and-prognosis-a-mendelian-randomization-study
#8
JOURNAL ARTICLE
Sicong Liu, Songwei Feng, Furong Du, Ke Zhang, Yang Shen
OBJECTIVE: Currently, the association between smoking, alcohol, and coffee intake and the risk of ovarian cancer (OC) remains conflicting. In this study, we used a two-sample mendelian randomization (MR) method to evaluate the association of smoking, drinking and coffee consumption with the risk of OC and prognosis. METHODS: Five risk factors related to lifestyles (cigarettes per day, smoking initiation, smoking cessation, alcohol consumption and coffee consumption) were chosen from the Genome-Wide Association Study, and 28, 105, 10, 36 and 36 single-nucleotide polymorphisms (SNPs) were obtained as instrumental variables (IVs)...
March 20, 2023: BMC Cancer
https://read.qxmd.com/read/36941557/leptin-and-leptin-receptor-expression-as-biomarkers-for-breast-cancer-a-retrospective-study
#9
JOURNAL ARTICLE
Yan Wang, Lili Du, Jiexian Jing, Xianwen Zhao, Xing Wang, Shenghuai Hou
BACKGROUND: Effective screening and treatment have reduced the number of women dying from breast cancer (BC). However, the long-term sequelae of BC treatment and psychosocial factors seriously affect the life quality of BC patients and survivors. Therefore, the discovery and application of targeted biomarkers to improve the functional outcome and life quality of BC patients is necessary. AIMS: To explore the impact of leptin (LEP)/ leptin receptor (LEPR) expression on occurrence and survival of BC...
March 20, 2023: BMC Cancer
https://read.qxmd.com/read/36941554/interaction-between-pd-l1-and-soluble-vegfr1-in-glioblastoma-educated-macrophages
#10
JOURNAL ARTICLE
Xin Liu, Zhenke Li, Jinxing Sun, Zhijie Zhang, Weiguo Li
PURPOSE: The combined application of immune checkpoint inhibitors (ICIs) and anti-angiogenesis therapy has shown synergistic effects on glioblastoma (GBM). As important resources of PD-L1 in the tumor microenvironment (TME), tumor-associated macrophages (TAMs) have significant impact of the efficiency of ICIs. However, the effects of anti-angiogenesis agents on immune checkpoints expression are not fully understood. METHOD: GBM-educated macrophages were generated from circulating monocytes of healthy controls and GBM patients under the education of GBM cell line...
March 20, 2023: BMC Cancer
https://read.qxmd.com/read/36934225/dnmt3a-low-expression-is-correlated-to-poor-prognosis-in-childhood-b-all-and-confers-resistance-to-daunorubicin-on-leukemic-cells
#11
JOURNAL ARTICLE
Weijing Li, Shugang Liu, Chanjuan Wang, Lei Cui, Xiaoxi Zhao, Wei Liu, Ruidong Zhang, Zhigang Li
BACKGROUND: Little is known about DNMT3A expression and its prognostic significance in childhood B cell acute lymphoblastic leukemia (B-ALL). METHODS: We determined DNMT3A mRNA expression in 102 children with B-ALL. Correlations with relapse-free survival (RFS) and common clinical characteristics were analyzed. DNMT3A was stably knocked out by CRISPR/Cas9 gene editing technology in Reh and 697 B-ALL cell lines. Cell proliferation activity after treated with daunorubicin (DNR) was determined by CCK8 assay in DNMT3A KO Reh and 697 cell lines...
March 18, 2023: BMC Cancer
https://read.qxmd.com/read/36932396/association-of-neutrophil-lymphocyte-ratio-with-survival-in-peripheral-early-stage-non-small-cell-lung-cancer-after-stereotactic-body-radiation-therapy
#12
JOURNAL ARTICLE
Karen Huang, Sharan Prasad, Sung Jun Ma, Han Yu, Austin J Iovoli, Mark K Farrugia, Elizabeth U Dexter, Todd L Demmy, Nadia K Malik, Anurag K Singh
BACKGROUND: The role of neutrophil-lymphocyte ratio (NLR) as a predictor for survival in single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear. We performed an observational cohort study to determine the role of pretreatment NLR in predicting survival of early-stage NSCLC patients after single fraction SBRT. METHODS: A single-institution database of peripheral early-stage NSCLC patients treated with SBRT from February 2007 to May 2022 was queried...
March 18, 2023: BMC Cancer
https://read.qxmd.com/read/36927771/clinical-outcomes-in-patients-with-solid-tumors-living-in-rural-and-urban-areas-followed-via-telemedicine-experience-in-a-highly-complex-latin-american-hospital
#13
JOURNAL ARTICLE
Juan Guillermo Restrepo, Juliana Alarcón, Andrés Hernández, Saveria Sangiovanni, Sofía González, Kelly Gallego, Evelyn E Peña-Zárate, Laura Libreros-Peña, María Fernanda Escobar
BACKGROUND: Difficulties in cancer services access increase the burden of disease and mortality in rural areas, and telehealth can be a useful tool to address these inequalities. OBJECTIVE: We aimed to describe the outcomes of patients in rural and urban areas with solid tumors managed by oncologists through telemedicine. METHODS: We conducted a retrospective cohort study of patients with solid tumors from March to December 2020. A total of 1270 subjects with solid tumors were included, 704 living in urban areas and 566 in rural areas...
March 16, 2023: BMC Cancer
https://read.qxmd.com/read/36927310/relationship-between-tumor-microbiota-transcriptional-activity-and-gene-expression-in-breast-cancer
#14
JOURNAL ARTICLE
Enuo Liu, Fan Zhang, Tiansheng Xu, Luyi Ye, Sean Si Qian Ma, Zai-Si Ji
BACKGROUND: A few studies have reported the distribution of the microbiota in breast cancer tissues, but few reports have compared the microbiota in different subtypes of breast cancer tissue. Moreover, no study has reported on the relationship between the microbiota and gene expression in breast tumor. METHODS: Sections of formalin-fixed paraffin-embedded (FFPE) tissue were prepared from the breast tumors of 70 patients and were subjected to microarray analysis to identify gene expression profiles...
March 16, 2023: BMC Cancer
https://read.qxmd.com/read/36922758/granulocyte-colony-stimulating-factor-does-not-prevent-in-vitro-cisplatin-induced-germ-cell-reduction-in-immature-human-and-mouse-testis
#15
JOURNAL ARTICLE
Gabriele Matilionyte, Grace Forsyth, Jingtao Guo, Michael P Rimmer, Brian P Hermann, Richard A Anderson, Rod T Mitchell
BACKGROUND: Currently there are no established fertility preservation options for pre-pubertal boys facing cancer treatment. Granulocyte-colony stimulating factor (G-CSF) treatment has been proposed to be chemoprotective against spermatogonial cell loss in an alkylating chemotherapy model of busulfan treated adult mice. Having previously shown that exposure to the alkylating-like chemotherapy cisplatin resulted in a reduction in germ cell numbers in immature human testicular tissues, we here investigate whether G-CSF would prevent cisplatin-induced germ cell loss in immature human and mouse (fetal and pre-pubertal) testicular tissues...
March 16, 2023: BMC Cancer
https://read.qxmd.com/read/36922805/neoadjuvant-chemoradiotherapy-plus-tislelizumab-followed-by-surgery-for-esophageal-carcinoma-crisec-study-the-protocol-of-a-prospective-single-arm-phase-ii-trial
#16
JOURNAL ARTICLE
Jinsong Yang, Ai Huang, Kunyu Yang, Ke Jiang
BACKGROUND: The failure rate after neoadjuvant chemoradiotherapy followed by surgery is approximately 34.6%-48% for resectable esophageal carcinoma. Pathologic complete response after neoadjuvant chemoradiotherapy is an important factor in predicting lower recurrence and better survival. Whether the sequential addition of immunotherapy to neoadjuvant chemoradiotherapy will be beneficial to improving the pathologic complete response rate is unknown. METHODS: Patients with pathologically confirmed thoracic esophageal squamous cell carcinoma and at clinical T1-2N1-3M0 or T3-4aN0-3M0 (stage II-IVA) according to the eighth edition of American Joint Committee on Cancer staging will be allocated to receive neoadjuvant radiotherapy (41...
March 15, 2023: BMC Cancer
https://read.qxmd.com/read/36922768/pre-diagnostic-anti-ebv-antibodies-and-primary-liver-cancer-risk-a-population-based-nested-case-control-study-in-southern-china
#17
JOURNAL ARTICLE
Yun Du, Xia Yu, Ellen T Chang, Shifeng Lian, Biaohua Wu, Fugui Li, Bing Chu, Kuangrong Wei, Jiyun Zhan, Xuejun Liang, Weimin Ye, Mingfang Ji
BACKGROUND: We aimed to investigate associations between pre-diagnostic anti-Epstein-Barr virus (EBV) antibodies, including interactions with hepatitis B virus (HBV), and risk of primary liver cancer in southern China. METHODS: In a population-based nested case-control study, we measured pre-diagnostic immunoglobulin A (IgA) against EBV nuclear antigen 1 (EBNA1) and viral capsid antigen (VCA) in 125 primary liver cancer cases and 2077 matched controls. We also explored the interaction between HBV surface antigen (HBsAg) and anti-EBV antibodies...
March 15, 2023: BMC Cancer
https://read.qxmd.com/read/36918865/impact-of-glucocorticoids-on-the-efficacy-of-neoadjuvant-chemoradiotherapy-and-survival-of-patients-with-locally-advanced-rectal-cancer-a-retrospective-study
#18
JOURNAL ARTICLE
Xiaoxue Huang, Zhiyuan Zheng, Bangwei Zeng, Han Xiao, Hao Zheng, Zhuangbin Lin, Jianyuan Song, Anchuan Li, Pan Chi, Yinghong Yang, Benhua Xu, Rong Zheng
BACKGROUND: Preclinical studies suggest that glucocorticoids (GCs) promote the proliferation and development of colorectal cancer. Because GCs are broadly prescribed for treatment-related adverse events in patients with locally advanced rectal cancer (LARC) receiving neoadjuvant chemoradiotherapy (NCRT), it's essential to assess the effect of GCs on clinical outcomes. METHODS: LARC cases treated with NCRT followed by surgery were assessed retrospectively. Evaluation of the relationship between GCs use (GCs vs...
March 14, 2023: BMC Cancer
https://read.qxmd.com/read/36918859/application-value-of-ki67-and-serum-ca125-in-the-deep-myometrial-invasion-of-endometrial-adenocarcinoma
#19
JOURNAL ARTICLE
Lin Qin
OBJECTIVE: To investigate the application value of Ki67 and serum CA125 in diagnosing the deep myometrial invasion of endometrial adenocarcinoma. METHODS: This study retrospectively analyzed 80 patients with endometrial adenocarcinoma, who underwent procedure from January 2018 to June 2021 at Senior Department of Obstetrics & Gynecology, the Seventh Medical Center of PLA General Hospital assigned to the Fourth Medical Center. The general clinical data, serum CA125 and Ki67 levels were compared between the superficial muscular infiltration group and the deep myometrial invasion group...
March 14, 2023: BMC Cancer
https://read.qxmd.com/read/36918840/the-expression-immune-infiltration-prognosis-and-experimental-validation-of-osbpl-family-genes-in-liver-cancer
#20
JOURNAL ARTICLE
Kunpeng Tian, Yongling Ying, Jingjing Huang, Hao Wu, Chengyue Wei, Liang Li, Longjun Chen, Lichuan Wu
BACKGROUND: Liver cancer is the third most deadly malignant tumor in the world with poor prognosis and lacks early diagnostic markers. It is urgent need to explore new biomarkers and prognostic factors. The oxysterol-binding protein-like family proteins (OSBPLs) are essential mediators of lipid transportation and cholesterol balancing which has been reported to participate in cancer progression. So far, the expression, immune infiltration, and prognosis of OSBPLs have not been elucidated in liver cancer...
March 14, 2023: BMC Cancer
journal
journal
35918
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.